About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AMGN - Amgen Inc.| Previous Close | $219.67 | Open | $218.22 |
| Volume | 2.75M | Market Cap | 131.38B |
| Yield | 0.0256% | Last Dividend | $5.67 |
| Alexion (ALXN) Up 10 % YTD on Soliris &a... | 6:58 AM |
| Alexion's (ALXN) stock rises 10% in the year so far as Soliris maintains momentum and Ultomiris gains further traction. | |
| Buy Big Biotech — But Not Gilead, Analys... | 11/12/19 |
| SunTrust initiated most of the big names in biotech with a Buy, but it was less sunny on two of the biggest names in the sector: Gilead Sciences and R... | |
| Should First Trust Capital Strength ETF ... | 11/12/19 |
| Style Box ETF report for FTCS | |
| Drugmaker Amgen cuts a quarter of its Ke... | 11/11/19 |
| The layoffs come just a few years after the California-based pharmaceutical company kicked off an expansion in New England. | |
| Amgen Highlights Data To Be Presented At... | 11/11/19 |
| THOUSAND OAKS, Calif., Nov. 11, 2019 /PRNewswire/ -- Amgen (AMGN) today announced that new data from its cardiovascular portfolio will be presented at... | |
| Amgen at 52-Week Highs Bumps Against Res... | 11/11/19 |
| Shares of biopharma giant Amgen have rallied more than 30% since their summer lows and recently hit all-time highs. Investors should now be cautious i... | |
| Biotech Funds Are Beating the Market, bu... | 11/08/19 |
| PiperJaffray analyst Christopher J. Raymond says investors took a net $99 million out of healthcare/biotech-dedicated funds in the week ended on Wedne... | |
| Amgen To Present At The 28th Annual Cred... | 11/07/19 |
| THOUSAND OAKS, Calif. , Nov. 7, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 28 th Annual Credit Suisse Healthcare Conference at 9:45 ... | |
| Radius (RDUS) Q3 Earnings Beat Estimates... | 11/06/19 |
| Radius (RDUS) reports a narrower-than-expected loss and beats sales estimates in the third quarter of 2019 as Tymlos gains traction. | |
| Ligand's (LGND) Q3 Earnings Miss Est... | 11/06/19 |
| Ligand (LGND) reports lower-than-expected third-quarter 2019 earnings. It also lowers outlook for 2019 earnings. However, revenues were better than ex... | |
| Top Analyst Reports for Verizon, McDonal... | 11/05/19 |
| Top Analyst Reports for Verizon, McDonald's & TOTAL | |
| Buy rating | 11/12/19 |
| SunTrust Robinson Humphrey initiates coverage with Buy rating and announces Price Target of $256.00 | |
| Strong Buy rating | 11/05/19 |
| Cantor Fitzgerald upgrades from Neutral to Overweight rating and raises Price Target from $230.00 to $255.00 | |
| Hold rating | 10/17/19 |
| and announces Price Target of $215.00 | |
| Hold rating | 09/05/19 |
| and raises Price Target from $221.00 to $230.00 | |
| Hold rating | 08/29/19 |
| JP Morgan maintains Neutral rating and raises Price Target from $191.00 to $198.00 | |
| Hold rating | 08/27/19 |
| RBC Capital maintains Sector Perform rating and raises Price Target from $192.00 to $206.00 | |
| Strong Buy rating | 08/27/19 |
| BMO Capital maintains Outperform rating and raises Price Target from $230.00 to $240.00 | |
| Hold rating | 08/19/19 |
| Mizuho downgrades from Buy to Neutral rating and raises Price Target from $208.00 to $212.00 | |
| Strong Buy rating | 08/16/19 |
| and raises Price Target from $202.00 to $225.00 | |
| Strong Buy rating | 08/13/19 |
| Oppenheimer maintains Outperform rating and raises Price Target from $210.00 to $230.00 | |
| Buy rating | 08/12/19 |
| Wells Fargo maintains Market Perform rating and raises Price Target from $197.00 to $202.00 | |
| Strong Buy rating | 07/15/19 |
| Morgan Stanley maintains Overweight rating and lowers Price Target from $211.00 to $207.00 | |
| Buy rating | 05/23/19 |
| Citigroup upgrades from Neutral to Buy rating and lowers Price Target from $211.00 to $205.00 | |
| Strong Buy rating | 05/21/19 |
| Credit Suisse initiates coverage with Outperform rating and announces Price Target of $208.00 | |
| Date | 2019-10-29 (AMC) | Est. (EPS/Rev.) | $3.52/ 5.64B |
| Actual (EPS/Rev.) | $3.66/ $5.74 B | EPS (TTM) | 13.11 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Alpha Swing Trades | Jonathan | 69.00 % | Follow |
| Hi America | Lawrence | 62.00 % | Subscribe |
| LetsGrow - Growth Stocks | BigMoveTrader | 58.00 % | Follow |
| Fibonacci Trading | Arez | 56.00 % | Subscribe |
| Burdeshaw Investing | Matthew Burdeshaw | 55.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
